Influenza virus vaccine oral - Provalis
Alternative Names: FlustatLatest Information Update: 25 Sep 2021
At a glance
- Originator Provalis; University of Newcastle, Australia
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 05 Feb 2008 Discontinued - Phase-I for Influenza virus infections in Australia (PO)
- 05 Feb 2008 Discontinued - Preclinical for Influenza virus infections in United Kingdom (PO)
- 17 Feb 2003 No development reported - Phase-I for Influenza virus infections in Australia (PO)